CompletedNot Applicable

Promoting Engagement in the Drug Resistant TB/HIV Care Continuum in South Africa

South Africa199 participantsStarted 2016-12

Plain-language summary

The goals of this research are to understand adherence and retention in care for multi-and extensively drug-resistant tuberculosis (M/XDR-TB) patients using a mixed methods approach.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years
✓. Mycobacterium Tuberculosis (MTB) culture positive with at least isoniazid and rifampicin resistance OR
✓. Initiating treatment for M/XDR-TB which includes at least 2 new medications
✓. Have capacity for informed consent
✓. HIV Positive Patients: on antiretroviral therapy (ART) or initiating ART within the following 4 weeks as per clinician recommendation

Exclusion criteria

✕. Pregnancy
✕. Prisoners
✕. Discretion of the Investigator of Record or clinician

What they're measuring

Medication adherence based on electronic monitoring

Timeframe: 6 months

Trial details

NCT IDNCT03162107

SponsorCentre for the AIDS Programme of Research in South Africa

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2020-01-10

View on ClinicalTrials.gov More Patient Non-compliance trials